Evidence map›Paper›PMID 33658774›Full record

Observational studyInternational journal of chronic obstructive pulmonary disease

Certified Smoking Cessation Units in Spain: High Potential for Detection of Undiagnosed Chronic Obstructive Pulmonary Disease and Profile of Newly Diagnosed Cases.

Juan-Antonio Riesco-Miranda, Segismundo Solano-Reina, Carlos Rábade-Castedo, José-Ignacio de Granda-Orive, Esther Pastor-Esplá, Marcos García-Rueda, Francisco-Javier Callejas-Gonzalez, Ángel Azpeitia-Anadón, Silvia Mas, Carlos-Andrés Jiménez-Ruiz

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in International journal of chronic obstructive pulmonary disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Juan-Antonio Riesco-MirandaServicio de Neumología, Hospital Universitario de Cáceres, Cáceres, Spain.ORCID 0000-0002-7418-0759
Segismundo Solano-ReinaServicio de Neumología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.ORCID 0000-0002-7611-0033
Carlos Rábade-CastedoServicio de Neumología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.ORCID 0000-0001-6832-3875
José-Ignacio de Granda-OriveServicio de Neumología, Hospital Universitario Doce de Octubre, Universidad Complutense de Madrid, Madrid, Spain.
Esther Pastor-EspláServicio de Neumología, Hospital Universitario San Juan de Alicante, Alicante, Spain.
Marcos García-RuedaServicio de Neumología, Hospital Universitario Carlos Haya, Málaga, Spain.
Francisco-Javier Callejas-GonzalezServicio de Neumología, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.ORCID 0000-0001-8213-5424
Ángel Azpeitia-AnadónDepartamento Médico Labs, Esteve S.A, Barcelona, Spain.
Silvia MasUniversidad Pompeu Fabra, Barcelona, Spain.
Carlos-Andrés Jiménez-RuizUnidad Especializada de Tabaquismo, Hospital Clínico Universitario, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSmokers attending smoking cessation units (SCUs) may offer a unique opportunity for early recognition of undiagnosed chronic obstructive pulmonary disease (COPD). We aimed at assessing the impact of SCUs on the early diagnosis of COPD and describing the clinical and smoking profile of newly-diagnosed COPD cases at SCUs certified by the Spanish Society of Respiratory Diseases and Thoracic Surgery (SEPAR). PATIENTS AND

methodsA multicenter cross-sectional observational cohort study (DIPREPOQ study) was performed in eight SEPAR-certified SCUs in Spain. Adult current smokers with no previously diagnosed respiratory disease and having one o more respiratory symptoms were included. Lung functional tests were performed and previously undiagnosed COPD cases were identified and characterized based on national guidelines.

resultsOut of 401 individuals newly attending the SCUs, 252 participants were included and 73 (28.9%) met the definition of previously undiagnosed COPD. A characterization of patients with COPD being newly recognized in SCUs showed: age (mean±SD) 61±9 years; men 59%; active work status 53.1%; functional class I/II dyspnea 82.8%, GOLD state mild/moderate/severe 57%/31%/12%; non-exacerbators 90%, CAT 14±4; emphysema in X-rays 40%. Most common co-morbidities were cardiovascular and psychiatric (anxiety and depression) ones. Usual smoking history included a lengthy smoking history (41±9 years) and a current consumption of 24±9 cigarettes/day. CONCLUSIONS AND IMPLICATIONS: Consistently certified SCUs can have a substantial contribution to early diagnosis of COPD. A typical profile of newly detected cases is reported, with most patients being men at their early sixties, with mild symptoms and with high and lengthy smoking history. Our study reports a high usefulness of lung functional tests to detect undiagnosed COPD in appropriately selected participants attending SCUs at a large national scale, using a standardized methodology. This is likely to be facilitated by the certification of SCUs using well-defined requirements by national scientific societies.

Indexed as

Pulmonary Disease, Chronic ObstructiveSmoking CessationAgedCertificationCross-Sectional StudiesHumansMiddle AgedSpainchronic obstructive pulmonary diseasehealth consequencessmokingsmoking cessation unit

Identifiers

PMID33658774
PMCPMC7920505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.